Craft Emerging Markets sold 79,800 shares of Trident Lifeline Limited for ₹2.26 Cr at ₹283.74 apiece in a bulk deal.
A pharmaceutical manufacturer incorporated in 2014, Trident Lifeline produces and distributes a comprehensive range of pharmaceutical products across India's healthcare sector. The company operates in the generics segment, focusing on formulations for various therapeutic areas and medical conditions. Its operations span manufacturing facilities, quality control protocols, and distribution networks designed to serve healthcare providers, hospitals, and patients nationwide through established channels.
Focused on emerging market equities including India.
